U.S. flag

An official website of the United States government

Display Settings:

Items per page

PMC Full-Text Search Results

Items: 6

1.
Figure 2

Figure 2. From: Lipid mediators in plasma of autism spectrum disorders.

Normal distribution for control and autistic groups in isoprostan (pg/ml).

Afaf El-Ansary, et al. Lipids Health Dis. 2012;11:160-160.
2.
Figure 4

Figure 4. From: Lipid mediators in plasma of autism spectrum disorders.

Normal distribution for control and autistic groups in PGE2 (pg/ml).

Afaf El-Ansary, et al. Lipids Health Dis. 2012;11:160-160.
3.
Figure 3

Figure 3. From: Lipid mediators in plasma of autism spectrum disorders.

Normal distribution for control and autistic groups in Leukotriene (pg/ml).

Afaf El-Ansary, et al. Lipids Health Dis. 2012;11:160-160.
4.
Figure 6

Figure 6. From: Lipid mediators in plasma of autism spectrum disorders.

ROC Curve of isoprostan (a)leukotriene (b) and PGE2(c) in autistic group.

Afaf El-Ansary, et al. Lipids Health Dis. 2012;11:160-160.
5.
Figure 1

Figure 1. From: Lipid mediators in plasma of autism spectrum disorders.

Percentage change with error bars of isoprostan (pg/ml), leukotriene (pg/ml) and PGE2 (pg/ml) in autistic group compared to control.

Afaf El-Ansary, et al. Lipids Health Dis. 2012;11:160-160.
6.
Figure 5

Figure 5. From: Lipid mediators in plasma of autism spectrum disorders.

Pearson correlations between the three measured parameters with the best fit line.

Afaf El-Ansary, et al. Lipids Health Dis. 2012;11:160-160.

Display Settings:

Items per page

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center